Alterity Therapeutics
ATHE
11 hedge funds and large institutions have $541K invested in Alterity Therapeutics in 2021 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 7 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
0% more repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 1
21% less funds holding
Funds holding: 14 → 11 (-3)
33% less capital invested
Capital invested by funds: $808K → $541K (-$267K)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Envestnet Asset Management
Chicago,
Illinois
|
+$89.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$66.8K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$14.8K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$4.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$15K |
| 2 |
VF
Virtu Financial
New York
|
-$14K |
| 3 |
HF
HRT Financial
New York
|
-$13K |
| 4 |
Morgan Stanley
New York
|
-$9.87K |
| 5 |
Wells Fargo
San Francisco,
California
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $403K | -$9.87K | -910 | -2% |
|
|
2
Envestnet Asset Management
Chicago,
Illinois
| $59K | +$89.4K | +8,239 | New |
|
|
3
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $44K | +$66.8K | +6,159 | New |
|
|
TSS
4
Two Sigma Securities
New York
| $15K | +$4.38K | +404 | +25% |
|
|
5
UBS Group
Zurich,
Switzerland
| $10K | +$14.8K | +1,360 | New |
|
6
Geode Capital Management
Boston,
Massachusetts
| $8K | – | – | – |
|
|
PCA
7
Providence Capital Advisors
Charlotte,
North Carolina
| $1K | – | – | – |
|
|
CA
8
CoreCap Advisors
Southfield,
Michigan
| $1K | +$239 | +22 | New |
|
|
9
Citadel Advisors
Miami,
Florida
| – | -$15K | -1,176 | Closed |
|
|
VF
10
Virtu Financial
New York
| – | -$14K | -1,135 | Closed |
|
|
HF
11
HRT Financial
New York
| – | -$13K | -1,061 | Closed |
|
|
12
Wells Fargo
San Francisco,
California
| – | -$3K | -250 | Closed |
|
|
GWM
13
Geneos Wealth Management
Englewood,
Colorado
| – | -$1K | -117 | Closed |
|
|
OIA
14
Optimum Investment Advisors
Chicago,
Illinois
| – | -$1K | -93 | Closed |
|
|
APA
15
American Portfolios Advisors
Holbrook,
New York
| – | -$105 | -8 | Closed |
|
ATHE Hedge Fund Activity: Q4 2021 in Review
11 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2021, worth a combined $541K — down 33% from $808K a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ATHE and 4 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 1 added.
The largest buyer was Envestnet Asset Management, opening a new position worth an estimated $89.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $15K sold.
- 11 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2021, down from 14 in Q3 2021.
- Funds reported $541K of Alterity Therapeutics stock for Q4 2021, down 33% quarter-over-quarter.
- 4 funds opened new Alterity Therapeutics positions in Q4 2021 and 7 closed out, a net change of -3 holders.
- The largest Alterity Therapeutics buyer in Q4 2021 was Envestnet Asset Management, an estimated $89.4K added.
- The largest Alterity Therapeutics seller in Q4 2021 was Citadel Advisors, an estimated $15K sold.
Based on aggregated 13F filings for Q4 2021.